A Win For TNF Pharmaceuticals, Inc.
Thu, Oct 02, 2025 at 08:30 PM
TNF Pharmaceuticals, Inc. (TNFA:NASDAQ) soared at $5.2, representing a gain of 48.1%. The stock appeared on our News Catalysts scanner on Wed, Sep 24, 2025 at 10:49 AM in the 'MISCELLANEOUS' category. From Fri, Sep 19, 2025, the stock recorded 22.22% Up Days and 10.00% Green Days
The stock spiked on Wed, Sep 24, 2025 at $8.94 with a volume of 60M+.
About TNF Pharmaceuticals, Inc. (TNFA:NASDAQ)
MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms.
Top 10 Gainers:
- Aspire Biopharma Holdings, Inc. (ASBP:NASDAQ), 95.71%
- Dragonfly Energy Holdings Corp. (DFLI:NASDAQ), 78.6%
- Concorde International Group Ltd. (CIGL:NASDAQ), 75.1%
- Boqii Holding Limited (BQ:NYSEMKT), 54.86%
- Taysha Gene Therapies, Inc. (TSHA:NASDAQ), 53.46%
- Borealis Foods Inc. (BRLS:NASDAQ), 53.35%
- SRAX, Inc. (SRAX:NASDAQ), 50%
- TNF Pharmaceuticals, Inc. (TNFA:NASDAQ), 48.15%
- Leap Therapeutics, Inc. (LPTX:NASDAQ), 38.81%
- Reviva Pharmaceuticals Holdings, Inc. (RVPH:NASDAQ), 35.12%